Samsung Biologics
207940.KS
#371
Rank
NZ$95.69 B
Marketcap
$1,345
Share price
1.30%
Change (1 day)
26.12%
Change (1 year)

Samsung Biologics (207940.KS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$7.46 Billion

According to Samsung Biologics 's latest financial reports the company's total liabilities are NZ$7.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Samsung Biologics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$7.59 B-19.94%
2022-12-31NZ$9.49 B158.93%
2021-12-31NZ$3.66 B57.4%
2020-12-31NZ$2.32 B16.46%
2019-12-31NZ$1.99 B-17.96%
2018-12-31NZ$2.43 B-42.45%
2017-12-31NZ$4.23 B2.49%
2016-12-31NZ$4.13 B4.36%
2015-12-31NZ$3.95 B368.75%
2014-12-31NZ$0.84 B